Minors-sale and purchase of cannabidiol prohibited.
Impact
The bill introduces a structured legal framework directing how CBD products can be sold and consumed in Wyoming, reinforcing age restrictions similar to existing regulations on alcohol and tobacco. It aims to mitigate the potential risks associated with underage access to CBD products, perceived by the sponsors as necessary to protect the health and safety of minors. Additionally, it allows for the expungement of certain hemp-related offenses, suggesting a progressive approach to the legal handling of cannabis-associated issues in the state.
Summary
House Bill HB0137 seeks to prohibit the sale and purchase of cannabidiol (CBD) products to individuals under the age of twenty-one. By establishing legal repercussions for violations, the bill aims to address concerns over the accessibility of CBD products by minors. The proposed legislation lays out specific penalties for both individuals and retailers who violate these prohibitions, categorizing such offenses as misdemeanors and imposing varying fines based on the number of violations.
Contention
While proponents, including some sponsors of the bill, assert that the regulation is essential for safeguarding minors, opponents may raise concerns about the restrictive nature of such legislation. Critics could argue that the bill does not address the broader context of cannabis use and may inadvertently lead to a stigma around hemp products, potentially limiting the benefits they may provide to both adults and the economy. The expungement provision also introduces complexities regarding prior convictions, which may lead to discussions about fairness and equity in the enforcement of marijuana-related laws.
Directs Cannabis Regulatory Commission to adopt regulations concerning labeling, marketing, and sale of cannabidiol and products containing cannabidiol; prohibits sale of cannabidiol to minors.
Directs Cannabis Regulatory Commission to adopt regulations concerning labeling, marketing, and sale of cannabidiol and products containing cannabidiol; prohibits sale of cannabidiol to minors.
Creating the Kansas medical cannabis act to authorize the cultivation, processing, distribution, sale and use of medical cannabis and medical cannabis products and the Kansas cannabidiol regulation act to regulate the testing and retail sale of cannabidiol products.
To provide for the regulation of industrial hemp, industrial hemp products, and industrial hemp-derived cannabidiol (CBD) products (EN INCREASE GF EX See Note)
Tobacco, nicotine and vapor products; purchase by minors; scope of certain crimes and penalties to include nicotine products; prohibitions pertaining to nicotine products; emergency.